Special Offer for "Currents" subscribers

Would you like a free ticket to the next San Diego Clinical Research Network (SDCRN) live program in San Diego? Or would you like a profile of yourself or your business published in an upcoming issue of "Currents"?  Then volunteer to share your thoughts in a 15-20 minute phone call about how "Currents" can help to meet your professional needs, and choose your "reward."  Contact teresa@clinicalresearchcurrents.com

TransCelerate launches“One Person Closer” campaign to increase awareness of clinical trials

TransCelerate BioPharma - a non-profit organization dedicated to simplifying and accelerating research and development of innovative new therapies – has launched its “One Person Closer” campaign to increase awareness of the need for clinical trial participants by inspiring healthcare professionals to incorporate the topic of research into their daily practices. (Cure)

ASCO urges industry to share real-world data for clinical trial efficiency

Sharing real-world data between CROs, sponsors and academic institutions will help improve trial design, says cancer association, American Society of Clinical Oncologists (“ASCO”.) (Outsourcing-Pharma.com)

Mayo Clinic finds success with IBM’s Watson for Clinical Trial Matching system

Mayo Clinic is an early user of the Watson for Clinical Trial Matching, an IBM system which uses artificial intelligence to quickly and accurately match patients to clinical trials for which they may be eligible. Mayo experienced an 80 percent increase in enrollment to their clinical trials for breast cancer while using this system. (Mayo Clinic news wise)

*Clinical Trials Day: focusing on awareness, the ‘war on talent,’ and an industry-wide commitment

Clinical Trials Day celebrates the first randomized clinical trial conducted in May 1747 and the clinical research professionals that work in the industry more than 265 years later. (Outsourcing-Pharma.com)

Pharma companies seek access to patient health records

Pharma companies are striking deals with technology companies to gain access to their big data analytics to unlock information from patient health records about how medicines perform in the real world.  It used to be hard to get information on how drugs work in routine clinical practice, but now we have electronic medical records and other databases which offer a wealth of patient-level data, or “real-world evidence.” (REUTERS)

Silicon Valley startup Atomwise gets $45 million investment to create drug design software

A Silicon Valley software startup that is using artificial intelligence to help drug designers find molecules that are worth pursuing just received $45 million in venture capital. Atomwise believes that their technology can be a solution to declining return on investment in the pharmaceutical industry, as it can save time and money in the Lead Optimization step, which is the most expensive step in drug development. (ENDPOINTS NEWS)

TransCelerate Biopharma aims to redesign the clinical trial registry

TransCelerate Biopharma, a nonprofit organization that brings together biopharmaceutical companies to simplify and accelerate research and development of innovative new therapies, has developed a proof of concept for a Clinical Trial Registry of the Future which simplifies the process of searching for specific clinical trials near a desired location. (KMWorld)

European Medicines Agency (EMA) publishes paper encouraging frailty assessment of clinical trial subjects

The European Medicines Agency (EMA) has finalized its reflection paper on the frailty of senior clinical trial participants after receiving feedback from the U.S. FDA. The purpose of the document is to encourage sponsors to assess the baseline frailty characteristics of trial subjects; notably, a frailty assessment could take 10-15 minutes and add to the burden on subjects and sites. (Regulatory Focus)

Untested meds dominate the Indian market

India has a prolific pharmaceutical industry which produces hundreds of innovative drugs to treat diabetes and other ailments, but the drugs have not gone through adequate clinical trials by World Health Organization guidelines. Most diabetes drugs in India are fixed dose combinations which produce greater profits, but have not been tested to determine how well they work or if they might cause side effects. (npr.org)

Are you an ACRP member?  Did you know….

All ACRP webinars are now included with your membership- that means they are now free to members. ACRP is hosting 24 live webinars in 2018, and members also have access to 40+ on-demand webinars (webinar replays). Non-members can also access ACRP webinars for a fee. (ACRP)

Don't forget to check the "Currents" website for free webinars and clinical research conferences.